What Azuca’s Gummy Test Reveals About the Limits of ‘Nano’

A tiny droplet can be measured with precision, yet the value of a cannabis gummy emerges across a much longer chain: the recipe, the production line, the shelf, and the person who eats it. A new white paper from Azuca argues that manufacturers should assess that entire chain when selecting an infusion system.

In Beyond Nano: A Performance-First Framework for Fast-Acting Cannabis Gummies, the New York company takes aim at the industry’s reliance on particle size as a convenient shorthand for efficacy. Its proposal draws attention to four connected questions: how a gummy feels and tastes, how it holds up as a product, what it demands of manufacturing, and what evidence supports the claims made about it.

The Measurement Problem

Nanoemulsion describes a delivery approach in which small oil droplets carrying cannabinoids are dispersed in water. Particle size can be measured before the ingredient enters a confectionery recipe, but a finished gummy presents a different chemical and physical environment. Heat, acidity, high solids, moisture balance, and storage conditions all matter to the product that eventually reaches a customer.

Azuca argues that an infusion’s water content can affect drying and texture, while surfactants used to stabilize an emulsion may influence flavor. The company also raises questions about potency retention and physical stability through distribution and shelf life. These are formulation considerations that manufacturers can test in their own recipes, with methods and thresholds suited to their products.

What a Gummy Changes

The manufacturing question is particularly consequential for a producer working at scale. An infusion that requires additional mixing equipment or changes a cook’s water balance can alter throughput, yield, and the time needed to reach a consistent texture. A supplier’s specification sheet supplies a useful starting measurement; a manufacturer still needs stability and sensory data from the actual gummy and process.

Azuca’s TiME INFUSION uses molecular encapsulation designed to give cannabinoids a water-friendly exterior. The company contrasts that mechanism with oil-in-water nanoemulsions and says its approach can reduce reliance on the emulsion interface and its associated surfactants. The white paper presents that as a potential formulation advantage, while the size of any benefit would depend on a particular recipe, comparator, and production conditions.

“I don’t care how small the particle is if I can taste the infusion.”Ron Silver, Azuca co-founder and chief creative officer

The Blind Comparison

To illustrate its case, Azuca reports an independent blind panel comparing a TiME INFUSION gummy with one professionally formulated nanoemulsion gummy at the same flavor and dose. According to the company, 86% of panelists rated the Azuca gummy’s taste good or very good, versus 60% for the comparator. Asked whether the effects resembled the character of inhaled flower, 53% selected the Azuca gummy and 36% selected the other product. Azuca says its gummy also scored higher on texture, overall liking, and purchase intent.

The comparison speaks directly to consumer perception, though the public release leaves several questions open. It does not state the number of panelists, the statistical uncertainty, the exact formulation of either gummy, or whether the effects question was supported by controlled pharmacokinetic measurements in that head-to-head trial. Comparing one product from each approach offers a useful test case, while broader claims about delivery technologies would require more formulations and transparent methods.

What the Evidence Can Show

Azuca points to human pharmacokinetic, preclinical, and real-world consumer research as further context for TiME INFUSION. Those bodies of evidence answer different questions. Blood-concentration studies can examine absorption over time; sensory panels capture preferences under defined conditions; shelf-life testing measures the stability of a specific finished product. Manufacturers can make a stronger decision by matching each claim to the kind of test that actually supports it.

That emphasis on finished-product measurements extends beyond Azuca’s own technology. Earlier Cannabis & Tech Today coverage of nanoemulsion testing described measuring droplets after they enter a food matrix and using human uptake studies to assess performance. The useful question for a formulator is therefore specific: how does this infusion behave in this gummy, under this production process, over the intended shelf life?

Azuca has offered a framework that makes that question harder to avoid. Its reported panel results provide a reason to examine the full study and request the underlying methods, while its four-part rubric gives manufacturers a practical way to compare suppliers on outcomes a label cannot capture. The white paper and companion research are available through Azuca’s site.

Source imagery:

Read Cannabis & Tech Today